Dr. Brian M. Curtin, MD
Orthopedic Surgery (Orthopaedic Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Georgetown University School of Medicine (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 566
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: Georgetown University School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Orthopaedic Surgery Physician primary
NC license 2010-00256
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Carolinas Medical Center/behav Health Charlotte, NC
- Novant Health Presbyterian Medical Center Charlotte, NC
Medical groups
- Comprehab, Inc (415 clinicians)
- Orthocarolina (301 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 566
- Services billed
- 1,983
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 360 | 61 |
| X-ray of knee, 3 views | 340 | 253 |
| Established patient office or other outpatient visit, 20-29 minutes | 255 | 237 |
| X-ray of hip, 2-3 views | 194 | 169 |
| Established patient office or other outpatient visit, 30-39 minutes | 186 | 164 |
| Aspiration and/or injection of fluid from large joint | 80 | 65 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 64 | 60 |
| New patient office or other outpatient visit, 45-59 minutes | 63 | 63 |
| Replacement of knee joint, both sides of knee | 61 | 55 |
| Replacement of thigh bone and hip joint with prosthesis | 58 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 37 payments worth $170,959 in total to this clinician.
| DePuy Synthes Products, Inc. | $140,199 |
|---|---|
| Vertex Pharmaceuticals Incorporated | $16,586 |
| Encore Medical, LP | $11,380 |
| Zimmer Biomet Holdings, Inc. | $1,218 |
| Heron Therapeutics, Inc. | $975 |
| Pacira Pharmaceuticals Incorporated | $216 |
| Smith+nephew, Inc. | $138 |
| Think Surgical, Inc. | $123 |
| Royalty or License | $140,199 |
|---|---|
| Consulting Fee | $26,481 |
| Travel and Lodging | $3,244 |
| Food and Beverage | $1,036 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| DePuy Synthes Products, Inc. Mar 21, 2025 | Royalty or License | $29,939 |
| DePuy Synthes Products, Inc. Jun 27, 2025 | Royalty or License | $28,411 |
| DePuy Synthes Products, Inc. Jan 13, 2025 | Royalty or License | $28,118 |
| DePuy Synthes Products, Inc. Sep 22, 2025 | Royalty or License | $28,092 |
| DePuy Synthes Products, Inc. Dec 22, 2025 | Royalty or License | $25,639 |
| Vertex Pharmaceuticals Incorporated Aug 27, 2025 | Consulting Fee JOURNAVX · ACUTE PAIN | $15,393 |
| Encore Medical, LP Jan 21, 2025 | Consulting Fee | $2,700 |
| Encore Medical, LP Dec 11, 2025 | Travel and Lodging travel to NY, NY · in-kind Company’s descriptionARVIS | $1,423 |
| Encore Medical, LP May 28, 2025 | Consulting Fee | $1,350 |
| Encore Medical, LP Aug 28, 2025 | Consulting Fee | $1,350 |
All 24 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| DePuy Synthes Products, Inc. Dec 22, 2025 | Royalty or License | $25,639 |
| Encore Medical, LP Dec 22, 2025 | Travel and Lodging travel to New York, NY · in-kind | $125 |
| Encore Medical, LP Dec 11, 2025 | Travel and Lodging travel to NY, NY · in-kind Company’s descriptionARVIS | $1,423 |
| Encore Medical, LP Dec 10, 2025 | Consulting Fee | $675 |
| Encore Medical, LP Sep 24, 2025 | Consulting Fee | $1,013 |
| DePuy Synthes Products, Inc. Sep 22, 2025 | Royalty or License | $28,092 |
| Encore Medical, LP Aug 28, 2025 | Consulting Fee | $1,350 |
| Vertex Pharmaceuticals Incorporated Aug 27, 2025 | Consulting Fee JOURNAVX · ACUTE PAIN | $15,393 |
| Vertex Pharmaceuticals Incorporated Aug 27, 2025 | Travel and Lodging JOURNAVX · ACUTE PAIN · travel to BOSTON, MA · in-kind | $413 |
| Vertex Pharmaceuticals Incorporated Aug 27, 2025 | Travel and Lodging JOURNAVX · ACUTE PAIN · travel to BOSTON, MA · in-kind | $31.92 |
| Vertex Pharmaceuticals Incorporated Aug 9, 2025 | Travel and Lodging JOURNAVX · PAIN · travel to BOSTON, MA · in-kind | $117 |
| Vertex Pharmaceuticals Incorporated Aug 8, 2025 | Travel and Lodging JOURNAVX · PAIN · travel to BOSTON, MA · in-kind | $539 |
| Heron Therapeutics, Inc. Jul 10, 2025 | Consulting Fee ZYNRELEF · POST SURGICAL PAIN RELIEF | $975 |
| Encore Medical, LP Jul 2, 2025 | Consulting Fee | $1,350 |
| DePuy Synthes Products, Inc. Jun 27, 2025 | Royalty or License | $28,411 |
| Encore Medical, LP Jun 26, 2025 | Consulting Fee | $338 |
| Encore Medical, LP Jun 24, 2025 | Consulting Fee | $338 |
| Zimmer Biomet Holdings, Inc. Jun 5, 2025 | Consulting Fee | $1,000 |
| Encore Medical, LP May 28, 2025 | Consulting Fee | $1,350 |
| DePuy Synthes Products, Inc. Mar 21, 2025 | Royalty or License | $29,939 |
| Encore Medical, LP Jan 21, 2025 | Consulting Fee | $2,700 |
| Encore Medical, LP Jan 21, 2025 | Travel and Lodging travel to Lewisville, TX | $561 |
| Encore Medical, LP Jan 21, 2025 | Travel and Lodging travel to Lewisville, TX | $35.00 |
| DePuy Synthes Products, Inc. Jan 13, 2025 | Royalty or License | $28,118 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $45,164 in research payments for these studies, mostly to the institutions running them.
- A Phase 3b, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Laparoscopic Procedures of the Intraperitoneal or Retroperitoneal Cavi…
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.